Anatomic Pathology Market is Likely to Surpass a Value of US$ 24 Billion By 2026
The Global Anatomic Pathology Market Size is estimated to cross Market Size of US$ 24 Billion by 2026 with a CAGR of 6% during the forecast period 2019 to 2026. The Anatomic Pathology Market By Market Analysis, Market Size, Opportunities, Revenue Status, Business Development and Forecast, 2019 to 2026 report has been added to Acumen Research and Consulting's offers.
The report analyzes and forecasts the Anatomic Pathology Market at global and regional levels. The market has been forecast based on volume (Unit) and value (US$) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
Download Free Sample Report Pages at https://www.acumenresearchandconsulting.com/request-sample/1525
The study provides a decisive view of the market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Market Players:
Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc.Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.
These main players implement various approaches in order to retain their important market share during the forecast period. Collaborative development, corporate development and product development are the strategies introduced.
For instance, in June 2018, Agilent Technologies introduced a range of probes, such as MALT1, MYC, BCL6, BCL2, CCND1, IGH, IGH / BCL2, IGH / MYC, and IGH /CCND1, for in situ hybridization. The launch of these products has improved the portfolio of the company and thus reinforced its place in the industry.
The Major Market Segments of Global Anatomic Pathology Market are as below:
Market Segmentation
Market, By Product and Service
Consumables
Reagents & Antibodies
Probes & Kits
Others
Instruments
Tissue processors
Automatic Stainers
Microtomes & Cryostat
Others
Services
Market, By Application
Drug Discovery & Development
Disease Diagnosis
Others
Market, By End-use
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Market, By Geography
North America.
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
The market research study on “Anatomic Pathology Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Anatomic Pathology market segments with market dynamics and their impact. The report also covers basic technology development policies.
View Detail Information with Complete TOC at https://www.acumenresearchandconsulting.com/anatomic-pathology-market
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Anatomic Pathology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Anatomic Pathology Market By Product and Service
1.2.2.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Product and Service (2015-2026)
1.2.2.2. Global Anatomic Pathology Market Revenue Share By Product and Service in 2017
1.2.2.3. Consumables
1.2.2.3.1. Reagents & Antibodies
1.2.2.3.2. Probes & Kits
1.2.2.3.3. Others
1.2.2.4. Instruments
1.2.2.4.1. Tissue processors
1.2.2.4.2. Automatic Stainers
1.2.2.4.3. Microtomes & Cryostat
1.2.2.4.4. Others
1.2.2.5. Services
1.2.3. Anatomic Pathology Market By Application
1.2.3.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Drug Discovery & Development
1.2.3.3. Disease Diagnosis
1.2.3.4. Others
1.2.4. Anatomic Pathology Market By End-use
1.2.4.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison By End-use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Diagnostic Laboratories
1.2.4.4. Research Laboratories
1.2.4.5. Others
1.2.5. Anatomic Pathology Market by Geography
1.2.5.1. Global Anatomic Pathology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Anatomic Pathology Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Anatomic Pathology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Anatomic Pathology Major Manufacturers in 2017
3.3. R&D Status and Technology Product and Service of Global Anatomic Pathology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Anatomic Pathology Major Manufacturers in 2017
CHAPTER 4. ANATOMIC PATHOLOGY MARKET BY PRODUCT AND SERVICE
4.1. Global Anatomic Pathology Revenue By Product and Service
4.2. Consumables
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Reagents & Antibodies
4.2.4. Probes & Kits
4.2.5. Others
4.3. Instruments
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Tissue processors
4.3.4. Automatic Stainers
4.3.5. Microtomes & Cryostat
4.3.6. Others
4.4. Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. ANATOMIC PATHOLOGY MARKET BY APPLICATION
5.1. Global Anatomic Pathology Revenue By Application
5.2. Drug Discovery & Development
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Disease Diagnosis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. ANATOMIC PATHOLOGY MARKET BY END-USE
6.1. Global Anatomic Pathology Revenue By End-use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Diagnostic Laboratories
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Research Laboratories
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY
7.1. North America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Anatomic Pathology Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE ANATOMIC PATHOLOGY MARKET BY COUNTRY
8.1. Europe Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET BY COUNTRY
9.1. Asia-Pacific Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA ANATOMIC PATHOLOGY MARKET BY COUNTRY
10.1. Latin America Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST ANATOMIC PATHOLOGY MARKET BY COUNTRY
11.1. Middle East Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA ANATOMIC PATHOLOGY MARKET BY COUNTRY
12.1. Africa Anatomic Pathology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Anatomic Pathology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product and Service, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End-use, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Boehringer Ingelheim GmbH
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Lonza
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Rentschler Biotechnologie GmbH
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. JRS Pharma (Celonic GmbH)
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. TOYOBO Biologics, LTD
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. FUJIFILM Diosynth Biotechnologies U.S.A.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Patheon
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. CMC Biologics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. WuXi Biologics
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1525
The report is readily available and can be dispatched immediately after payment confirmation.
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.